Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Ginekol Pol ; 93(8): 637-642, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35419797

RESUMEN

OBJECTIVES: The aim of this study was to analyse the obstetric patients who underwent transfusion in the gynecology and obstetrics clinic. MATERIAL AND METHODS: Obstetric patients who underwent a blood transfusion in the peripartum period were included in the study. A total of 213 patients who needed blood transfusion were identified. Patients' age, gravida, parity, gestational week, delivery types, blood transfusion indication and time, transfusion rate, blood products used, number of transfusions, peripartum hysterectomy status, neonatal APGAR scores and hemoglobin (Hb), hematocrit (Hct), red blood cell (RBC), platelet (Plt) values which counted before and after transfusion were recorded by scanning patient files from the hospital registry system. RESULTS: The overall blood transfusion rate of the patients who gave birth in our clinic was 2.51%. Uterine atony (50.7%) and chronic anemia (32.9%) were found as the most frequent indications of blood transfusion in the patients included in the study. Antenatal mean Hb of all transfusion patients was 9.8; postpartum mean Hb was 8.2. Pre-transfusion mean Hb, RBC, Hct, Plt values calculated as 7, 3.9, 30.3, 245.2, respectively; post-transfusion mean Hb, RBC, Hct, Plt values were 9, 3.52, 27.5, 215.1, respectively. CONCLUSIONS: Due to blood replacement, supply difficulties and transfusion complications, the profit-loss relationship should be individualized and clearly demonstrated before it is applied to the patient. In unpredictable obstetric situations that cause bleeding, staying up to date on current guidelines on pharmacological, hematological and surgical interventions and having an active blood transfusion center in the healthcare provider is very important in reducing maternal mortality and morbidity rates.


Asunto(s)
Anemia , Transfusión de Eritrocitos , Recién Nacido , Humanos , Femenino , Embarazo , Transfusión de Eritrocitos/efectos adversos , Estudios Retrospectivos , Transfusión Sanguínea , Hemoglobinas/análisis , Anemia/epidemiología , Anemia/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA